IFF to acquire Health Wright Products, a leader in custom formulation and encapsulation

Health Wright Products has been a long-time partner of IFF’s Health & Biosciences probiotics business.

IFF (New York) has entered into an agreement to acquire Health Wright Products LLC (HWP; Clackamas, OR), a leader in formulation and capsule manufacturing for the dietary supplement industry. HWP is a long-time partner of IFF’s Health & Biosciences probiotics business. Using state-of-the-art processes and equipment, HWP manufactures custom formulations and delivers encapsulation and packaging to meet the exacting requirements of probiotics. The company has generated approximately $100 million in annual revenue in 2021, employs over 225 people, and has over 165,000 square feet of manufacturing space. All its employees will continue to work with the company after the acquisition.

“Today’s announcement is driven by our commitment to enhance long-term value to our partners and customers. Producing thousands of unique and complex formulations for the industry’s most trusted brands, Health Wright Products formulation and finished format abilities will allow us to develop new and customized solutions and formats for a broad base of customers,” said Simon Herriott, president, IFF’s Health & Biosciences division, in a press release.

“We look forward to joining IFF’s Health & Biosciences division. Health Wright Products best-in-class quality manufacturing and formulation capabilities, combined with the strong biotech innovation pipeline of IFF’s Health & Biosciences, is an exciting proposition for our customers and employees,” said Mark Wright, president, Health Wright Products.